Nuveen Asset Management, LLC Igm Biosciences, Inc. Transaction History

Nuveen Asset Management, LLC

  • $340 Billion
  • Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 45,015 shares of IGMS stock, worth $57,169. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,015
Previous 45,015 -0.0%
Holding current value
$57,169
Previous $744,000 63.04%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$6.28 - $17.68 $26,790 - $75,422
4,266 Added 10.47%
45,015 $744,000
Q1 2024

May 13, 2024
SELL
$8.68 - $17.36 $78,762 - $157,524
-9,074 Reduced 18.21%
40,749 $393,000
Q4 2023

Feb 14, 2024
SELL
$3.94 - $8.79 $115,694 - $258,109
-29,364 Reduced 37.08%
49,823 $414,000
Q2 2023

Aug 14, 2023
SELL
$8.86 - $14.0 $17,560 - $27,748
-1,982 Reduced 2.44%
79,187 $730,000
Q1 2023

May 15, 2023
SELL
$13.74 - $25.76 $26,586 - $49,845
-1,935 Reduced 2.33%
81,169 $1.12 Million
Q4 2022

Feb 14, 2023
BUY
$15.45 - $26.02 $585,864 - $986,678
37,920 Added 83.92%
83,104 $1.41 Million
Q3 2022

Nov 14, 2022
SELL
$15.42 - $27.01 $655,427 - $1.15 Million
-42,505 Reduced 48.47%
45,184 $1.03 Million
Q2 2022

Aug 15, 2022
BUY
$13.27 - $25.5 $813,145 - $1.56 Million
61,277 Added 232.0%
87,689 $1.58 Million
Q1 2022

May 16, 2022
BUY
$13.42 - $29.73 $33,952 - $75,216
2,530 Added 10.59%
26,412 $420,000
Q4 2021

Feb 14, 2022
SELL
$27.59 - $66.39 $195,171 - $469,642
-7,074 Reduced 22.85%
23,882 $700,000
Q3 2021

Nov 12, 2021
SELL
$65.76 - $90.65 $568,889 - $784,213
-8,651 Reduced 21.84%
30,956 $2.04 Million
Q2 2021

Aug 16, 2021
BUY
$57.98 - $96.6 $391,191 - $651,760
6,747 Added 20.53%
39,607 $3.3 Million
Q1 2021

May 17, 2021
BUY
$71.56 - $121.23 $231,138 - $391,572
3,230 Added 10.9%
32,860 $2.52 Million
Q4 2020

May 17, 2021
SELL
$47.41 - $115.03 $171,434 - $415,948
-3,616 Reduced 10.88%
29,630 $2.62 Million
Q4 2020

Feb 16, 2021
SELL
$47.41 - $115.03 $882,157 - $2.14 Million
-18,607 Reduced 35.88%
33,246 $2.94 Million
Q3 2020

Nov 16, 2020
SELL
$43.0 - $84.01 $115,799 - $226,238
-2,693 Reduced 4.94%
51,853 $3.83 Million
Q2 2020

Aug 14, 2020
BUY
$51.3 - $75.21 $1.81 Million - $2.66 Million
35,350 Added 184.15%
54,546 $3.98 Million
Q1 2020

May 14, 2020
BUY
$31.51 - $73.75 $358,520 - $839,127
11,378 Added 145.54%
19,196 $1.08 Million
Q4 2019

Feb 14, 2020
BUY
$17.25 - $49.51 $134,860 - $387,069
7,818 New
7,818 $298,000

Others Institutions Holding IGMS

# of Institutions
8
Shares Held
942K
Call Options Held
0
Put Options Held
0
View Full List

About IGM Biosciences, Inc.

IGMS Quotes by TradingView
  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $36.8M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email